Extra Ordinary General Meeting of the Company to be held on Wednesday, 12th day of November, 2025 at 10: 00 a.m. through Video Conference / Other Audio- Visual Means ( VC/OAVM)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jeevan Scientific Technology has called an EGM on November 12, 2025 at 10:00 AM (via VC/OAVM) to seek shareholder approval for four key items. The company plans to increase its authorised share capital from Rs. 21 crore to Rs. 25 crore (2.50 crore shares of Rs. 10 each). It proposes to issue 35 lakh fully convertible warrants at Rs. 40 each (Rs. 10 face value + Rs. 30 premium) to promoters (30 lakh) and one non-promoter (5 lakh), potentially raising up to Rs. 14 crore, convertible within 18 months with 25% upfront payment. Additionally, it proposes to issue up to 41.85 lakh equity shares at Rs. 40 each on a preferential basis to 24 non-promoter allottees, aggregating Rs. 16.74 crore. The price is set at a slight premium over the independent valuation of Rs. 39.67 per share. Total potential capital raise is around Rs. 30.74 crore. Post-issue, promoter holding will marginally rise from 38.05% to 38.37%, with no change in control.
If approved, existing shareholders will see modest dilution (~32% on a fully diluted basis) as the share count rises from ~1.58 crore to ~2.35 crore shares. The capital infusion strengthens the company's balance sheet for growth, but the preferential nature means benefits accrue to selected allottees rather than all shareholders. Short-term stock price may face pressure due to dilution and the premium pricing is marginal.